Currently, many circulating tumor markers such as carcinoembryonic antigen, CA19-9, CA125, CA50, and alpha-fetoprotein have been tested in the clinic for GC detection; however, none of them has optimal sensitivity and specificity [42]. The gene discussed is AFP; the disease is neoplasm.